Differential Influence on Cytotoxic T Lymphocyte Epitope Presentation by Controlled Expression of Either Proteasome Immunosubunits or Pa28

The proteasome is the principal provider of major histocompatibility complex (MHC) class I–presented peptides. Interferon (IFN)-γ induces expression of three catalytically active proteasome subunits (LMP2, LMP7, and MECL-1) and the proteasome-associated activator PA28. These molecules are thought to optimize the generation of MHC class I–presented peptides. However, known information on their contribution in vivo is very limited. Here, we examined the antigen processing of two murine leukemia virus-encoded cytotoxic T lymphocyte (CTL) epitopes in murine cell lines equipped with a tetracycline-controlled, IFN-γ–independent expression system. We thus were able to segregate the role of the immunosubunits from the role of PA28. The presence of either immunosubunits or PA28 did not alter the presentation of a subdominant murine leukemia virus (MuLV)-derived CTL epitope. However, the presentation of the immunodominant MuLV-derived epitope was markedly enhanced upon induction of each of these two sets of genes. Thus, the IFN-γ–inducible proteasome subunits and PA28 can independently enhance antigen presentation of some CTL epitopes. Our data show that tetracycline-regulated expression of PA28 increases CTL epitope generation without affecting the 20S proteasome composition or half-life. The differential effect of these IFN-γ–inducible proteins on MHC class I processing may have a decisive influence on the quality of the CTL immune response.

[1]  P. Kloetzel,et al.  Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes , 2000, The Journal of experimental medicine.

[2]  J. Monaco,et al.  Identification of MECL-1 (LMP-10) as the third IFN-gamma-inducible proteasome subunit. , 1996, Journal of immunology.

[3]  M. Kasahara,et al.  The MHC class I ligand‐generating system: roles of immunoproteasomes and the interferon‐4gMY‐inducible proteasome activator PA28 , 1998, Immunological reviews.

[4]  C. Slaughter,et al.  Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). , 1992, The Journal of biological chemistry.

[5]  C. Slaughter,et al.  A Model for the Quaternary Structure of the Proteasome Activator PA28* , 1996, The Journal of Biological Chemistry.

[6]  Marcus Groettrup,et al.  Incorporation of major histocompatibility complex – encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon‐γ , 1995, European journal of immunology.

[7]  D. Schatz,et al.  A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K Eichmann,et al.  Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. , 1995, Immunity.

[9]  Hans-Georg Rammensee,et al.  A role for the proteasome regulator PA28α in antigen presentation , 1996, Nature.

[10]  Hans-Georg Rammensee,et al.  Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands , 1996, Cell.

[11]  A. Goldberg,et al.  Degradation of cell proteins and the generation of MHC class I-presented peptides. , 1999, Annual review of immunology.

[12]  P. Kloetzel,et al.  A third interferon‐γ‐induced subunit exchange in the 20S proteasome , 1996, European journal of immunology.

[13]  K. Tanaka,et al.  Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes. , 1998, The Biochemical journal.

[14]  N. Tanahashi,et al.  Proteasomes and antigen processing. , 1997, Advances in immunology.

[15]  P M Kloetzel,et al.  Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes , 1994, The Journal of experimental medicine.

[16]  P. Cresswell,et al.  Mechanisms of MHC class I--restricted antigen processing. , 1998, Annual review of immunology.

[17]  Y. Murakami,et al.  Hybrid Proteasomes , 2000, The Journal of Biological Chemistry.

[18]  A. Vitiello,et al.  Impaired immunoproteasome assembly and immune responses in PA28-/- mice. , 1999, Science.

[19]  J. Neefjes,et al.  Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation , 1992, Nature.

[20]  K. Schwarz,et al.  The proteasome inhibitor lactacystin prevents the generation of an endoplasmic reticulum leader-derived T cell epitope. , 1998, Molecular immunology.

[21]  J. Monaco,et al.  Sequence and expression of mouse proteasome activator PA28 and the related autoantigen Ki , 1997, Immunogenetics.

[22]  K. Rajewsky,et al.  MHC class I expression in mice lacking the proteasome subunit LMP-7. , 1994, Science.

[23]  M. Ressing,et al.  Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice , 1994, Journal of virology.

[24]  C. Slaughter,et al.  Relative Functions of the α and β Subunits of the Proteasome Activator, PA28* , 1997, The Journal of Biological Chemistry.

[25]  P. Henklein,et al.  Expression and subcellular localization of mouse 20S proteasome activator complex PA28 , 1997, FEBS letters.

[26]  K. Tanaka,et al.  Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma , 1996, The Journal of experimental medicine.

[27]  K. Ferrell,et al.  Purification of an 11 S regulator of the multicatalytic protease. , 1992, The Journal of biological chemistry.

[28]  C. Melief,et al.  Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors , 1998, The Journal of experimental medicine.

[29]  J. Darlix,et al.  An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors , 1995, Journal of virology.

[30]  M. Feltkamp,et al.  Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. , 1995, Journal of immunology.

[31]  W. Kast,et al.  Cytotoxic T lymphocytes against the antigen‐processing‐defective RMA‐S tumor cell line , 1992, European journal of immunology.

[32]  C. Melief,et al.  Cytotoxic T cell response against lymphoblasts infected with Moloney (Abelson) murine leukemia virus. Methodological aspects and H‐2 requirements , 1981, European journal of immunology.

[33]  H. Pircher,et al.  Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein , 1995, The Journal of experimental medicine.

[34]  Peter M. Kloetzel,et al.  MHC Class I Antigen Processing of an Adenovirus CTL Epitope Is Linked to the Levels of Immunoproteasomes in Infected Cells1 , 2000, The Journal of Immunology.

[35]  B. Chesebro,et al.  Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors , 1996, Journal of virology.

[36]  W. Kast,et al.  Differential effect of transporter Tap 2 gene introduction into RMA‐S cells on viral antigen processing , 1993, European journal of immunology.

[37]  S. Ōmura,et al.  Potential Immunocompetence of Proteolytic Fragments Produced by Proteasomes before Evolution of the Vertebrate Immune System , 1997, The Journal of experimental medicine.

[38]  T. Jessell,et al.  Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord , 1994, Cell.

[39]  P. Kloetzel,et al.  The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Tonegawa,et al.  Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.

[41]  P M Kloetzel,et al.  Abrogation of CTL Epitope Processing by Single Amino Acid Substitution Flanking the C-Terminal Proteasome Cleavage Site1 , 2000, The Journal of Immunology.

[42]  A. Ciechanover,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[43]  Y. Murakami,et al.  Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. , 2000, The Journal of biological chemistry.

[44]  久松浩.  Newly Identified Pair of Proteasomal Subunits Regulated Reciprocally by Interferon γ , 1997 .

[45]  A. Goldberg,et al.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.